Plus Therapeutics Inc (PSTV) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access PSTV Annual Balance Sheets →
Quarterly balance sheet trends provide context on Plus Therapeutics Inc's liquidity, leverage, and long-term financial structure.
Quarterly Report, GAAP in USD millions
ITEM
(Jun 30 2026)
(Mar 31 2026) (Dec 31 2025) (Sep 30 2025) (Jun 30 2025)
Assets
Cash & cash equivalent2.37
Restricted Cash and Cash Equivalents, Current0.00
Short-term Investments, Total6.22
Cash & Short-term Investments8.00
Grants Receivable, Current1.76
Derivatives, Collateral, Regulatory, Deferred0.24
Other Current Assets0.21
Total loans net0.97
Total Current Assets11.77
Equipment/Property/Plant Net1.41
Goodwill net0.37
Intangible Assets0.27
Other Assets, Noncurrent0.21
Grant Receivable-
Operating Lease Right Of Use Asset0.07
Total Assets14.03
Liabilities
Accounts Payable and Accrued Liabilities, Current LI7.55
Line of Credit, Current LO0.00
Other Liabilities, Current1.02
Total Current Liabilities8.57
Total Long-term Debt0.00
Other liabilities, Noncurrent0.00
Operating Lease Liability Current0.06
Warrant Liability Noncurrent-
Operating Lease Liability Noncurrent0.02
Total Liabilities8.57
Stockholders' Equity
Treasury Stock Common Value-0.50
Common Stock Value0.01
Additional Paid In Capital Common Stock537.77
Retained Earnings / Accumulated Deficit-531.82
Other Equity0.00
Common Stockholder's Equity5.46
Total Stockholder's Equity5.46
Liabilities & Stockholder's Equity14.03
4 historic quarters locked

Sign in to unlock the full Plus Therapeutics Inc balance sheet history.

About Cerenome Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001193125-26-352444

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.